"信東" 1.49%氯化鉀/0.9%氯化鈉注射液
Country: Taívan
Tungumál: kínverska
Heimild: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Upplýsingar fylgiseðill
(PIL)
22-12-2020
Opinber matsskýrsla
(PAR)
26-03-2020
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
POTASSIUM CHLORIDE;;SODIUM CHLORIDE
Fáanlegur frá:
信東生技股份有限公司 桃園市桃園區介壽路２２號 (43211700)
ATC númer:
B05XA01
Lyfjaform:
注射液劑
Samsetning:
POTASSIUM CHLORIDE (4012001800) MG; SODIUM CHLORIDE (4012002100) MG
Einingar í pakka:
塑膠瓶裝;;盒裝
Tegund:
製 劑
Gerð lyfseðils:
限由醫師使用
Framleitt af:
信東生技股份有限公司 桃園市桃園區介壽路２２號 TW
Lækningarsvæði:
potassium chloride
Ábendingar:
適用於無法採用口服治療之鉀缺乏症。本高濃度、即拆即用的氯化鉀注射液乃專為因限制水份，而不能提供額外的低濃度鉀溶液的病人維持血清鉀濃度補充鉀離子之用。
Vörulýsing:
有效日期: 2025/11/18; 英文品名: 1.49% KCl in 0.9% NaCl Injection "TBC"
Leyfisdagur:
2015-11-18
Upplýsingar fylgiseðill
“
”
1.49%
/
0.9%
1.49%
KCL in
0.9%
NaCl Injection
“TBC”
200 MEQ/L
1.49% KCl in 0.9% NaCl Injection
708 mOsmol/L
USP(
)
USP
mEq /
(g/
L)
*
(mOsmol/L)
(calc)
pH
(mEq/L)
Sodium
Chloride
(NaCl)
USP(KCI)
20mEq/100mL
9
14.9
708
5.0(4.0~8.0)
200
200
*
260-310 mOsmol/L
mOsmol/L)
Each m
L contains:
Potassium Chloride ············· 14.9mg
Sodium Chloride ····················· 9mg
Water for Injection
(300
400 mEq/L)
2.5 mEq/
10 mEq
24
200 mEq(should not usually exceed 10 mEq/hour or 200 mEq
for a 24 hour period)
2.0 mEq/(
2.0 mEq//
)
40 mEq
24
400 mEq(400 mEq over a 24 hour
period)
parenteral solutions
(Digitalis)
(
)
(300400
mEq/L)
/
(solute)
(congested states)
(1)
A.
B.
(2)
A.
B.
Coring
C.
C.
65
()
T (peaked T waves)
P-R
P
DRS
(hypervolemia)
(
)
1.
ACE
2.
Digitalis
3.
1. (regular insulin
glucose )
2.
(retention enema)
3.
(
160 mEq)
80
90%
25
100
100
058767
22
54161200
1
2016102001_氯化鉀-0.9%氯化鈉注射液-仿單 1
尺寸
: 210 x 297 mm
料號
:
54161200-1
Lestu allt skjalið
